Regulating clinical trials in a resource-limited setting during the Ebola public health emergency in Sierra Leone
This article explored the decisions taken by the Pharmacy Board of Sierra Leone through its Expert Committee on Medicine Safety and Clinical Trials regarding clinical trials oversight during the Ebola epidemic and the lessons learned. This independent expert committee assessed and provided scientific opinions to the Pharmacy Board of Sierra Leone to inform approval of all clinical trials within 10 –15 working days. We also requested for assisted review from the African Vaccine Regulatory Forum and support from the US Food and Drug Administration through a unilateral recognition and reliance memorandum of understanding. I...
Source: Trials - June 6, 2022 Category: Research Source Type: clinical trials
An AI Model Based on Smartphone-derived Multimodality Images to Evaluate Portal Hypertension in Patients With Cirrhosis (CHESS2203)
Condition: Portal Hypertension Intervention: Diagnostic Test: Hepatic venous pressure gradient Sponsors: Hepatopancreatobiliary Surgery Institute of Gansu Province; Taiyuan Third People's Hospital; QuFu People's Hospital; Shenyang Sixth People's Hospital; LanZhou University; Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region; Fifth Medical Cent er of Chinese PLA General Hospital; Tsinghua University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2022 Category: Research Source Type: clinical trials
